|
BCL2L13 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.53529999614E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.9059000000432E-07 |
| Normal-vs-Stage2 |
1.130000E-01 |
| Normal-vs-Stage3 |
1.434040E-02 |
| Normal-vs-Stage4 |
1.51179999963169E-07 |
| Stage1-vs-Stage2 |
1.697820E-01 |
| Stage1-vs-Stage3 |
4.438200E-01 |
| Stage1-vs-Stage4 |
4.483700E-02 |
| Stage2-vs-Stage3 |
5.300800E-01 |
| Stage2-vs-Stage4 |
1.934330E-02 |
| Stage3-vs-Stage4 |
2.782200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.01349999959544E-07 |
| Normal-vs-AfricanAmerican |
3.33739999969218E-07 |
| Normal-vs-Asian |
8.710100E-02 |
| Caucasian-vs-AfricanAmerican |
3.588400E-01 |
| Caucasian-vs-Asian |
1.980190E-01 |
| AfricanAmerican-vs-Asian |
4.547200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.11260000049229E-07 |
| Normal-vs-Female |
3.04360000003001E-06 |
| Male-vs-Female |
6.585600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.75660000001754E-07 |
| Normal-vs-Extreme_Weight |
9.57160000036872E-07 |
| Normal-vs-Obese |
7.819400E-04 |
| Normal-vs-Extreme_Obese |
2.547000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.726200E-01 |
| Normal_Weight-vs-Obese |
1.709800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.265800E-02 |
| Extreme_Weight-vs-Obese |
4.079400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.371800E-01 |
| Obese-vs-Extreme_Obese |
5.036200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.845700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.37060000005018E-06 |
| Normal-vs-Age(61-80Yrs) |
8.3815999996073E-07 |
| Normal-vs-Age(81-100Yrs) |
4.803300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.788600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.267400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.935400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.287800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.143200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.238200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.84839996034236E-09 |
| Normal-VS-Type2 PRCC |
2.131700E-02 |
| Normal-VS-KIRP CIMP |
1.243550E-02 |
| Normal-VS-Unclassified PRCC |
3.402300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.431600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.464800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.956150E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.376000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.386200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.095000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.622200E-03 |
| Normal-vs-N1 |
8.923800E-03 |
| Normal-vs-N2 |
1.776840E-04 |
| N0-vs-N1 |
6.130000E-01 |
| N0-vs-N2 |
3.281000E-01 |
| N1-vs-N2 |
4.594000E-01 |
|
|
